Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 224 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 2741 results:
Author Title Type [ Year(Asc)]
2019
N. S. Nagra, Robinson, D. E., Douglas, I., Delmestri, A., Dakin, S. G., Snelling, S. J. B., Carr, A. J., and Prieto-Alhambra, D., “Antibiotic treatment and flares of rheumatoid arthritis: a self-controlled case series study analysis using CPRD GOLD”, Sci Rep, vol. 9, p. 8941, 2019.
C. Hopkins, Williamson, E., Morris, S., Clarke, C. S., Thomas, M., Evans, H., Little, P., Lund, V. J., Blackshaw, H., Schilder, A., Philpott, C., Carpenter, J., and Denaxas, S., “Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records”, Rhinology, 2019.
A. A. Sultan, Mallen, C., Muller, S., Hider, S., Scott, I., Helliwell, T., and Hall, L. J., “Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study”, BMC Med, vol. 17, p. 154, 2019.
F. S. Troelsen and Jick, S., “Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink”, Inflamm Bowel Dis, 2019.
L. A. Garcia Rodriguez, Martin-Perez, M., Vora, P., Roberts, L., Balabanova, Y., Brobert, G., Fatoba, S., Suzart-Woischnik, K., Schaefer, B., and Ruigomez, A., “Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK”, BMJ Open, vol. 9, p. e031341, 2019.
R. Hoile, Tabet, N., Smith, H., Bremner, S., Cassell, J., and Ford, E., “Are symptoms of insomnia in primary care associated with subsequent onset of dementia? A matched retrospective case-control study”, Aging Ment Health, pp. 1-6, 2019.
J. L. Walker, Zhao, H., Dabrera, G., Andrews, N., Thomas, S. L., Tsang, C., Ellis, J., Donati, M., and Pebody, R. G., “Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015”, J Infect Dis, 2019.
P. Kasteridis, Ride, J., Gutacker, N., Aylott, L., Dare, C., Doran, T., Gilbody, S., Goddard, M., Gravelle, H., Kendrick, T., Mason, A., Rice, N., Siddiqi, N., Williams, R., and Jacobs, R., “Association Between Antipsychotic Polypharmacy and Outcomes for People With Serious Mental Illness in England”, Psychiatr Serv, p. appips201800504, 2019.
S. H. Landis, Pimenta, J. M., Yang, S., Compton, C., Barnes, N., and Brusselle, G., “Association between blood eosinophils and acute exacerbation of COPD risk in patients with COPD in primary care”, Respiratory Medicine, vol. 1, 2019.
J. Vavanikunnel, Charlier, S., Becker, C., Schneider, C., Jick, S. S., Meier, C. R., and Meier, C., “Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study”, J Clin Endocrinol Metab, 2019.
G. Nakafero, Grainge, M. J., Myles, P. R., Mallen, C. D., Zhang, W., Doherty, M., Nguyen-Van-Tam, J. S., and Abhishek, A., “Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink”, Ann Rheum Dis, 2019.
Y. M. F. Andersen, Egeberg, A., Ban, L., Gran, S., Williams, H. C., Francis, N. A., Knop, F. K., Gislason, G. H., Skov, L., and Thyssen, J. P., “Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts”, Diabetes Care, vol. 42, pp. 1095-1103, 2019.
R. Williams, Kothny, W., Serban, C., Lopez-Leon, S., de Vries, F., and Schlienger, R., “Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study”, Endocrinol Diabetes Metab, vol. 2, p. e00084, 2019.
F. Montastruc, Nie, R., Loo, S., Rej, S., Dell'Aniello, S., Micallef, J., Suissa, S., and Renoux, C., “Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide”, JAMA Psychiatry, 2019.
S. Abtahi, Burden, A. M., Geusens, P., van den Bergh, J. P., Van Staa, T., and de Vries, F., “The Association of Oral Bisphosphonate Use With Mortality Risk Following a Major Osteoporotic Fracture in the United Kingdom: Population-Based Cohort Study”, J Am Med Dir Assoc, 2019.
A. Root, Brown, J. P., Forbes, H. J., Bhaskaran, K., Hayes, J., Smeeth, L., and Douglas, I. J., “Association of Relative Age in the School Year With Diagnosis of Intellectual Disability, Attention-Deficit/Hyperactivity Disorder, and Depression”, JAMA Pediatr, 2019.
K. E. Lowe, Mansfield, K. E., Delmestri, A., Smeeth, L., Roberts, A., Abuabara, K., Prieto-Alhambra, D., and Langan, S. M., “Atopic eczema and fracture risk in adults: A population-based cohort study”, J Allergy Clin Immunol, 2019.
Y. Schonmann, Mansfield, K. E., Hayes, J. F., Abuabara, K., Roberts, A., Smeeth, L., and Langan, S. M., “Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study”, J Allergy Clin Immunol Pract, 2019.
T. M. Anssar, Leitzmann, M. F., Linker, R. A., Meier, C., Becker, C., Jick, S., Sahm, K., Platten, M., Hau, P., and Seliger, C., “Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma”, Cancer Med, 2019.
B. A. Dickerman, Garcia-Albeniz, X., Logan, R. W., Denaxas, S., and Hernan, M. A., “Avoidable flaws in observational analyses: an application to statins and cancer”, Nat Med, 2019.
R. Alsaggaf, St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., Liu, Z., Koshiol, J., Bauer, A. J., Wagner, K. R., Greene, M. H., Amr, S., and Gadalla, S. M., “Benign tumors in myotonic dystrophy type I target disease-related cancer sites”, Ann Clin Transl Neurol, vol. 6, pp. 1510-1518, 2019.
N. Ismail, Jordan, K. P., Kadam, U. T., Edwards, J. J., Kinnaird, T., and Mamas, M. A., “Bleeding After Hospital Discharge Following Acute Coronary Syndrome: Incidence, Types, Timing, and Predictors”, J Am Heart Assoc, vol. 8, p. e013679, 2019.
O. A. Oshagbemi, Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., and de Vries, F., “Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD)”, Copd, pp. 1-8, 2019.
J. Gregson, Qizilbash, N., Iwagami, M., Douglas, I., Johnson, M., Pearce, N., and Pocock, S., “Blood pressure and risk of dementia and its subtypes: a historical cohort study with long-term follow-up in 2.6 million people”, Eur J Neurol, vol. 26, pp. 1479-1486, 2019.
H. Strongman, Brown, A., Smeeth, L., and Bhaskaran, K., “Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals”, Br J Cancer, 2019.
S. Y. Loo, Azoulay, L., Nie, R., Dell'Aniello, S., Yu, O. H. Y., and Renoux, C., “Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study.”, Am J Med, 2019.
A. K. Wright, Kontopantelis, E., Emsley, R., Buchan, I. E., Mamas, M. A., Sattar, N., Ashcroft, D. M., and Rutter, M. K., “Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities”, Circulation, 2019.
A. Gilsenan, Fortuny, J., Cainzos-Achirica, M., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L., Harding, A., Kollhorst, B., Karlsson, P., Linner, L., MacDonald, T. M., Odsbu, I., Plana, E., Ruigomez, A., Schink, T., Ziemiecki, R., and Andrews, E. B., “Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study”, Drug Saf, 2019.
M. A. C. Tanke, Feyman, Y., Bernal-Delgado, E., Deeny, S. R., Imanaka, Y., Jeurissen, P., Lange, L., Pimperl, A., Sasaki, N., Schull, M., Wammes, J. J. G., Wodchis, W. P., and Meyer, G. S., “A challenge to all. A primer on inter-country differences of high-need, high-cost patients”, PLoS One, vol. 14, p. e0217353, 2019.
A. V. Gayle, Axson, E. L., Bloom, C. I., Navaratnam, V., and Quint, J. K., “Changing causes of death for patients with chronic respiratory disease in England, 2005-2015”, Thorax, 2019.
S. V. Ramagopalan, Carroll, R., Ulvestad, M., Mehmud, F., and Alikhan, R., “The changing face of venous thromboembolism management in England”, Future Cardiol, 2019.
L. Kalilani, Friesen, D., Boudiaf, N., and Asgharnejad, M., “The characteristics and treatment patterns of patients with Parkinson's disease in the United States and United Kingdom: A retrospective cohort study”, PLoS One, vol. 14, p. e0225723, 2019.
S. Ramtoola, Nyeland, M. E., Jacobsen, J., Ploug, U. J., Kragh, N., and Zimmermann, E., “Characteristics of newly diagnosed adults with type 1 diabetes in the UK and evolution of glycaemic control, body mass index and Charlson comorbidity index over the first 5 years after diagnosis”, Prim Care Diabetes, 2019.
den C. Heijer, Hoebe, C., Driessen, J. H., Wolffs, P., van den Broek, I., Hoenderboom, B., Williams, R., de Vries, F., and Dukers-Muijrers, N., “Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients”, Clinical Infectious Diseases, 2019.
S. Menon, Nightingale, P., and Trudgill, N., “Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study”, J Clin Gastroenterol, 2019.
V. Kuan, Denaxas, S., A Izquierdo, G. -, Direk, K., Bhatti, O., Husain, S., Sutaria, S., Hingorani, M., Nitsch, D., Parisinos, C. A., Lumbers, T., Mathur, R., Sofat, R., Casas, J. P., Wong, I. C. K., Hemingway, H., and Hingorani, A. D., “A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service”, The Lancet Digital Health, 2019.
R. Persson and Jick, S., “Clinical implications of the association between fluoroquinolones and tendon rupture: the magnitude of the effect with and without corticosteroids”, Br J Clin Pharmacol, 2019.
L. Fiaschi, Nelson-Piercy, C., Deb, S., King, R., and Tata, L. J., “Clinical management of nausea and vomiting in pregnancy and hyperemesis gravidarum across primary and secondary care: a population based study”, Bjog, 2019.
F. Nissen, Douglas, I. J., Mullerova, H., Pearce, N., Bloom, C. I., Smeeth, L., and Quint, J. K., “Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink)”, J Asthma Allergy, vol. 12, pp. 7-19, 2019.
D. Metcalfe, Masters, J., Delmestri, A., Judge, A., Perry, D., Zogg, C., Gabbe, B., and Costa, M., “Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases”, BMC Med Res Methodol, vol. 19, p. 115, 2019.
A. Dregan, Matcham, F., Harber-Aschan, L., Rayner, L., Brailean, A., Davis, K., Hatch, S., Pariante, C., Armstrong, D., Stewart, R., and Hotopf, M., “Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation”, Ann Rheum Dis, 2019.
A. Schultze, Graham, S., Nordstrom, B. L., Mehmud, F., and Ramagopalan, S. V., “Commonly used definitions in real-world studies may underestimate the prevalence of renal disease among nonvalvular atrial fibrillation patients”, J Comp Eff Res, 2019.
M. Nowakowska, Zghebi, S. S., Ashcroft, D. M., Buchan, I., Chew-Graham, C., Holt, T., Mallen, C., van Marwijk, H., Peek, N., Perera-Salazar, R., Reeves, D., Rutter, M. K., Weng, S. F., Qureshi, N., Mamas, M. A., and Kontopantelis, E., “The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort”, BMC Med, vol. 17, p. 145, 2019.
I. J. Chou, Kuo, C. F., Tanasescu, R., Tench, C. R., Tiley, C. G., Constantinescu, C. S., and Whitehouse, W. P., “Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality”, Eur J Neurol, 2019.
A. Douros, Dell'Aniello, S., Yu, O. H. Y., and Suissa, S., “Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study”, Diabetes Obes Metab, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice”, Chest, 2019.
S. J. Sinnott, Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., and Douglas, I. J., “The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data”, Pharmacoepidemiol Drug Saf, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD”, Chest, 2019.
D. B. Price, Carter, V., Martin, J., Gardener, E. A., Skinner, D., Yang, S., Hoffman, M., Willis, J. C., and Cooper, A. J., “Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting beta2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care”, Drugs, 2019.
K. Mansfield, Crellin, E., Denholm, R., Quint, J. K., Smeeth, L., Cook, S., and Herrett, E., “Completeness and validity of alcohol recording in general practice within the UK: a cross-sectional study”, BMJ Open, vol. 9, p. e031537, 2019.
[Page last reviewed 8 March 2021]